ArticleLife (Basel, Switzerland)2026

Targeted Cepharanthine-Mediated Dual-Pathway Inhibition Sensitizes Pancreatic Cancer to Gemcitabine.

Tongshan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.